Tubulin polymerization inhibitor for cancer therapy
AssigneeBoard of Regents, The University of Texas System
InventorsRenato J. Aguilera, Edgar A. Borrego Puerta
Life of this patent
Estimating the term…
Abstract
Provided herein is a compound and method for treating cancer cells. The method comprises administering cancer cells with a compound having the chemical structure of 2-{4-[4-methoxy-3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}-N-(2-methyl-2H-1,2,3-triazol-4-yl)acetamide to induce apoptosis of the cancer cells and inhibit tubulin polymerization.
Claims2
A method of inducing apoptosis of cancer cells, the method comprising administering the cancer cells with a compound comprising the chemical structure of 2-{4-[4-methoxy-3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}-N-(2-methyl-2H-1,2,3-triazol-4-yl)acetamide.
A method of inhibiting tubulin polymerization of cancer cells, the method comprising administering the cancer cells with a compound comprising the chemical structure of 2-{4-[4-methoxy-3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}-N-(2-methyl-2H-1,2,3-triazol-4-yl)acetamide.
Dependencies are inferred from the claim text.